85 Homozygosity for the C 677 ¡ T mutation of 5,10methylenetetrahydrofolate reductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden
Several case-control studies have shown elevated total plasma homocysteine and homozygosity for the point mutation C677T in the gene for the 5,10-methylenetetrahydrofolate reductase (MTHFR) to be associated with an increased risk of atherosclerotic vascular disease. In this prospective cohort study including 78 cases having developed, after sampling, a first myocardial infarction, and 156 controls matched for sex and age, we found no significant differences among the prevalence of the three possible MTHFR genotypes or the mean levels of total plasma homocysteine between the patient or the control groups. In this study, neither homozygosity for the point mutation C677T in the gene for MTHFR nor homocysteinemia was related to the occurrence of a first myocardial infarction in the population of northern Sweden. Rolf T. Fuessl, Eva Kranenberg, Ulf Kiausch, Frank M. Baer, Udo Sechtem and Hans W. Höpp Authors of previous studies have demonstrated that vascular remodeling is a bidirectional process. To enhance the understanding of underlying mechanisms we analyzed potential influences of the composition of plaque on vascular remodeling in coronary artery lesions. Seventy-seven de-novo coronary lesions in 70 patients were examined using intravascular ultrasound imaging before intervention. Composition of plaques was related to vascular remodeling. We found a predominantly expansive remodeling in sonographically soft lesions and a higher prevalence of constrictive remodeling among calcified lesions. These results suggest that constrictive remodeling is a late manifestation of atherosclerosis, whereas compensatory enlargement of vessels would seem to occur early. We examined plasma levels of macrophage-colony stimulating factor and transforming growth factor-␤ and cytokinegeneration capacities of monocytes in 34 consecutive patients before and 3-6 months after percutaneous transluminal coronary angioplasty. The levels of macrophage-colonystimulating factor in patients with restenosis ( >50% loss of the initial gain) increased significantly, whereas those in patients without restenosis decreased significantly. Only in patients with restenosis the generation capacity of interleukin-1␣ and interleukin-1␤ increase significantly, whereas plasma levels of C-reactive protein decreased significantly only in patients without restenosis. These results suggest that inflammatory changes mediated by cytokines may be involved in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty.
Vascular remodeling in atherosclerotic coronary arteries is affected by plaque composition

Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects
On the wide spectrum of abnormalities in the coronary arteries of Whipple's disease Thomas N. James
There is a long history of suspicion that coronary disease can be caused by infections but recent interest in the possibility has grown rapidly. Presence of the microbe causing Whipple's disease is readily demonstrable with the periodic-acid-Schiff stain. In an archival collection of tissue from patients who had died from Whipple's disease the bacillus was present within many coronary arteries and caused a wide spectrum of morphologic abnormalities with and without associated inflammation. Information on the cellular and subcellular lesions thus described might be useful as a paradigm for further studies of the infectious etiology of atherosclerosis.
Diagnostic Methods
127 Quantitative assessment of diffuse coronary artery disease using a three-dimensional reconstruction method compared with intravascular ultrasound images Taketsugu Tsuchiya, Masami Shimizu, Hiroyuki Yoshio, Hidekazu Ino, Kasuyasu Okeie, Toshihiko Yasuda and Hiroshi Mabuchi It can be difficult to estimate the degree of stenosis in patients with diffuse coronary artery disease by using a visual method or computerized quantification because of the lack of normal reference segments. We therefore developed a method that allows us to calculate true size of normal arterial lumen for the dependent coronary vascular bed or regional myocardial mass using clinical coronary arteriograms with three-dimensional reconstruction. This method provides a novel approach to quantifying diffuse coronary artery disease.
Therapy and Prevention 135 Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital
Charles L. Lucore, Robert V. Trask, Gregory J. Mishkel, Krishna J. Rocha-Singh, Marc E. Shelton, Frank L. Mikell and Robert W. Ligon To assess the costs and outcomes of coronary stenting and balloon angioplasty with and without adjunctive abciximab, we evaluated 3758 consecutive elective percutaneous interventions over a 2.5-year period. Abciximab use was more frequent in patients with acute coronary syndromes and more complex coronary lesions. Abciximab and stenting were associated with significant independent effects on risk of subsequent cardiovascular events. Stent and abciximab utilization were independent predictors of increased hospital cost. The lack of stenting was identified as a significant predictor for repeat revascularization procedures. These findings are in general agreement with the cost analysis of recent clinical trials and suggests the improvements in clinical outcome with abciximab treatment and stenting justifies the incremental cost of treatment.
143 The influence of short-term treatment with simvastatin on the inflammatory profile of patients with hypercholesterolaemia Ewa Deskur-Śmielecka, Andrzej Wykrȩtowicz, Magdalena Kempa, Jaromir Furmaniuk and Henryk Wysocki
Results of this preliminary study show that treatment of hypercholesterolaemic patients with a 3-hydroxy-3methylglutaryl coenzyme A reductase inhibitor (simvastatin) for 12 weeks is associated with a decrease in peroxidation of lipids and a diminution of concentrations in plasma of end products of nitric oxide. Also, plasma levels of the proinflammatory cytokine interleukin 6 are not affected by the short-term therapy with simvastatin.
Features
Perspectives in Pharmacology and Therapeutics 149 Diabetes and coronary artery disease -therapy and outcomes John D. Rutherford
